百日咳鲍特菌病:某儿童医院在孕产妇免疫策略实施前(2003-2011年)与实施后(2013-2016年)的比较
阿根廷某儿童医院纳入2003年12月至2016年12月PCR确诊的百日咳鲍特菌(Bp)病例,比较2012年推荐孕妇接种Tdap疫苗前(2003-2011年)与后(2013-2016年)的住院率与死亡率变化。结果显示实施后病例年龄更大(3 vs 9个月,p<0.001),住院比例降低(86.9% vs 67.6%,p<0.001),住院率下降(22.3 vs 11.6,p<0.001),实施前死亡率5.9%(14例)而实施后无死亡(p=0.036)。
要点
- 实施前(PreV)237例、实施后(PostV)71例,PostV病例年龄较PreV更大(3 vs 9个月,p<0.001)。
- PostV住院比例较PreV降低(86.9% vs 67.6%,p<0.001),住院率下降(22.3 vs 11.6,p<0.001)。
- PreV死亡率5.9%(14例),PostV无死亡(p=0.036)。
核心结论
- 实施孕产妇Tdap免疫推荐后,本中心Bp确诊病例年龄更大,住院率显著下降,且无死亡病例。
研究设计与样本
- 回顾性分析阿根廷「R. Gutierrez」儿童医院2003年12月至2016年12月PCR确诊的Bp病例,排除干预年2012年,比较2003-2011年(PreV)与2013-2016年(PostV)两个时段。
主要发现
- 研究期间共1046例疑似Bp病例,其中337例(32.2%)确诊,排除2012年后分析308例:PreV 237例,PostV 71例。
- 与PreV相比,PostV病例年龄更大(3 vs 9个月;p<0.001),需要住院的比例更低(86.9% vs 67.6%;p<0.001)。
- Bp住院率(HR)下降(22.3 vs 11.6;p<0.001)。
- PreV死亡率为5.9%(14例),PostV无死亡(p=0.036)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Whooping cough continues to be a major cause of morbidity and mortality in infants younger than 1 year. In 2012, Argentina introduced Tdap in pregnancy to prevent infant mortality. The aim of this study is to describe the impact of maternal immunization on the hospitalization and mortality rates of confirmed Bordetella pertussis (Bp) cases by comparing pre- and post-Tdap vaccine recommendation periods. MATERIAL AND METHODS: All PCR-confirmed Bp cases from "R. Gutierrez" Children's Hospital identified between December 2003 and December 2016 were included in. Analysis was performed comparing hospitalization rates (per 10,000 discharges) between pre-vaccination (PreV) 2003-2011 and post-vaccination (PostV) 2013-2016 time periods, excluding the intervention year (2012). RESULTS: During the study time frame, there were 1046 suspected Bp cases, of which 337 (32.2%) were confirmed. Three-hundred eight cases were analyzed (excluding year 2012): 237 in PreV and 71 in PostV. In comparison with PreV, PostV cases were older (3 vs 9 months; p < 0.001), and required less hospitalization (86.9% vs 67.6%; p < 0.001). Bp hospitalization rate (HR) decreased (22.3 vs 11.6; p < 0.001). The mortality rate in PreV 5.9% (14 cases); there were not deaths during PostV (p = 0.036). CONCLUSIONS: Confirmed cases were among infants younger than 1 year In PostV, Bp cases were older and there was a significant decrease in the hospitalization rate. There were no fatal cases in our center after the pregnancy Tdap recommendation was implemented.
引用
- Gentile A, Juarez MDV, Lucion MF, et al. Bordetella pertussis (Bp) disease: Before (2003-2011) and after (2013-2016) maternal immunization strategy in a pediatric hospital. Vaccine. 2018. PMID: 29429812. doi:10.1016/j.vaccine.2018.01.091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。